The Effect of the Treatment Program "Dr. Fedon Lindbergs Vektcoach" on Body Weight and Composition and Hormonal Profile

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01235208
Recruitment Status : Completed
First Posted : November 5, 2010
Last Update Posted : August 15, 2012
Information provided by (Responsible Party):
Eurodiet Scandinavia AS

Brief Summary:

The background for the trial is a number of previous studies indicating that it is especially important to restrict the intake of carbohydrates when treating overweight and metabolic diseases in general.

The purpose of the study is to obtain research data on the effects of an established treatment of overweight/obesity and its related metabolic disorders. The treatment, "Dr. Fedon Lindbergs Vektcoach", is a combination treatment where patients use low carbohydrate and low energy "Eurodiet" products in the initial phases. After the initial phases are completed, low glycemic normal foods are added to the diet until a sustainable and healthy diet is achieved. The treatment is of 7 month duration.

Condition or disease Intervention/treatment Phase
Overweight Obesity Metabolic Syndrome Other: The "Dr. Fedon Lindbergs Vektcoach" Treatment Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 44 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: The Effect of a Low Carbohydrate Low Energy Ketogenic Diet Followed by Progressively Increased Intake of Low Glycemic Foods Over 7 Months on Weight and Body Composition and Hormonal Profile
Study Start Date : October 2010
Actual Primary Completion Date : August 2012
Actual Study Completion Date : August 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Body Weight
U.S. FDA Resources

Arm Intervention/treatment
Experimental: Eurodiet treatment Other: The "Dr. Fedon Lindbergs Vektcoach" Treatment
Diet and lifestyle treatment

Primary Outcome Measures :
  1. Body weight/composition [ Time Frame: 7 months ]

Secondary Outcome Measures :
  1. Hormonal profile [ Time Frame: 7 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Body Mass Index (BMI)>35
  • BMI>27 + one risk factor for cardiovascular disease or metabolic syndrome
  • >18 years

Exclusion Criteria:

  • Medicinal treatment of thyroid disease
  • Pregnancy or planned pregnancy
  • Taking of diet pills like Xenical or Sibutramine

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01235208

Dr. Fedon Lindbergs Klinikk
Oslo, Norway
Sponsors and Collaborators
Eurodiet Scandinavia AS
Principal Investigator: Pål T Jåbekk, M.Sc
Study Director: Arne T Høstmark, Ph.D/Dr.Med Unaffiliated/ Study supervisor

Responsible Party: Eurodiet Scandinavia AS Identifier: NCT01235208     History of Changes
Other Study ID Numbers: EDstudy
First Posted: November 5, 2010    Key Record Dates
Last Update Posted: August 15, 2012
Last Verified: August 2012

Keywords provided by Eurodiet Scandinavia AS:
Metabolic syndrome
Low glycemic index

Additional relevant MeSH terms:
Metabolic Syndrome X
Body Weight
Signs and Symptoms
Insulin Resistance
Glucose Metabolism Disorders
Metabolic Diseases